Search results for: Health Policy and Regulation
Filter search results
Projecting Expenditure on Medicines in the NHS: Second Edition
1 January 2014
The Pharmaceutical Price Regulation Scheme (PPRS) 2014 Heads of Agreement, announced on 6 November 2013, outlines the terms of the five-year deal between the pharmaceuctical industry and the government in…
EU Approval of Biosimilars
8 July 2010
…Gopalan Narayanan is a medical assessor at the MHRA (Biologicals and Biotechnology Unit) and a member of several EMEA committees and working parties. Publication now available for download: Mattison, N., Mestre-Ferrandiz, J. and…
OHE is Pleased to Announce the Appointment of Two New Economists: Margherita Neri and Jimena Ferraro
14 February 2017
…promotion. Jimena’s current research interests include industrial organisation, competition policy, regulation, and health economics. She has carried out research to study different competitive environments and their effects on market structures,…
Consolidation and Competition in the Pharmaceutical Industry
9 January 2001
…are also increasing their expenditure and involvement with biotechnology and other specialised research companies by way of alliances and licence deals. Kettler analyses the nature and the implications for R&D…
Brittany Darrow
2 October 2024
…particularly interested in rare diseases and the impact of pricing and payment models on innovation and health system sustainability. She is a member of OHE’s economics of innovation (EoI) theme. …
How Fair? Competition between Independent and NHS Providers to Supply Non-Emergency Hospital Care to NHS Patients in England
1 September 2009
Written while Labour Government policies still were in force, this Briefing clearly and thoroughly examines non-discretionary cost differences between public and independent providers that may have a serious impact on…
Working Towards a Sustainable, Healthy Market for Vaccines: a Comprehensive Framework to Support Policy Dialogue and Decision-Making
1 September 2021
By placing a strain on health care systems and the global economy, the COVID-19 pandemic clearly shows the need to more comprehensively understand both supply- and demand-side aspects of a…
Valuing Health at the End of Life: An Exploratory Preference Elicitation Study
1 December 2011
…facie, support for NICE’s end of life policy. However, the ways in which information on patient age and the timing of treatment affected responses was not straightforward and in some…
An EQ-5D-5L Value Set for England
30 October 2014, 12:00am
…relating to how best to elicit and model preferences, and to produce an EQ-5D-5L value set for England. Professor Nancy Devlin at the Office of Health Economics and Professor…